This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag
by Zacks Equity Research
CME Group's Q1 results reflect improved revenues and increased volatility that aided volumes.
CME (CME) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for CME (CME) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) Q1 Earnings Top Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 0.36% and 0.46%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Great Southern Bancorp and Five Below have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Great Southern Bancorp and Five Below are part of the Zacks Bull and Bear of the Day article.
5 Most Important Earnings Charts to Watch Right Now
by Tracey Ryniec
Tariffs, AI Revolution, Gold, Trading, and the Consumer. Watch these 5 stocks this week.
3 U.S. Securities and Exchanges Stocks to Buy on Solid Industry Trends
by Nalak Das
Buy 3 U.S. Securities and Exchanges stocks to strengthen your portfolio. These are CME, CBOE, ICE.
Will Trading Volume Aid CME Group to Deliver Q1 Earnings Beat?
by Zacks Equity Research
CME's first-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Curious about CME (CME) Q1 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Momentum Anomaly Stocks to Buy as Markets Rise on Tariff Pause
by Supriyo Bose
JWN, EXE and CME are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Top Stock Picks for Week of April 14, 2025
by Panel Of Zacks Experts
A Financial Technology Company Expected to Offer Substantial Upside Potential and a Futures Exchange with Solid Estimate Activity.
CME Group (CME) Is Up 2.78% in One Week: What You Should Know
by Zacks Equity Research
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
Global Week Ahead: A U.S./China Trade War Sequel
by John Blank
It's a new trading world out there in the wake of the tariff turmoil. John Blank analyzes how this conflict will impact this week's market events around the globe and also spotlights three Zacks Rank #1 (Strong Buy) stocks worth watching.
Are Finance Stocks Lagging CME Group (CME) This Year?
by Zacks Equity Research
Here is how CME Group (CME) and British Land Company PLC Sponsored ADR (BTLCY) have performed compared to their sector so far this year.
CME Group (CME): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
CME Group (CME) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
CME Group and GMS have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
CME Group and GMS have been highlighted as Zacks Bull and Bear of the Day.
Bull of the Day: CME Group (CME)
by Bryan Hayes
CME leads with about 90% market share of global futures trading and clearing services.
Wall Street's Wild Ride: What Tuesday's Rally Means for Investors
by Andrew Rocco
While many beaten-down stocks registered large bounces yesterday, the immediate path ahead is murky for investors, at best. Stock Strategist Andrew Rocco explains.
ICE (ICE) Soars 3.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
ICE (ICE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Top Analyst Reports for Procter & Gamble, Novo Nordisk & PepsiCo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novo Nordisk A/S (NVO) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks Genie Energy Ltd. (GNE) and Canterbury Park Holding Corporation (CPHC).
Best Momentum Stock to Buy for April 9th
by Zacks Equity Research
HSNGY, BABA and CME made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 9, 2025.
CME Gains 11% YTD: Time to Buy the Stock at a P/E of 23.82X?
by Tanuka De
Let us delve deeper to find out what to do with CME Group stock now.